SlideShare a Scribd company logo
INFLUENZA
Including avian

Chapter 31
Avian Influenza
Influenza
• Febrile respiratory disease with systemic symptoms

caused by a variety of other organisms often called „flu
• Birds, swine, other mammals also affected
• Highly infectious and can spread rapidly from person to
person
• Some strains cause more severe illness than others
History of influenza
• 412 BC - first mentioned by

Hippocrates
• 1580 - first pandemic

described
• 1580-1900 - 28 pandemics
Types of influenza viruses
• Influenza viruses divided into 3main types: influenza

A, B, and C
• A viruses
• infect birds and other animals, as well as humans
• source of seasonal influenza epidemics and all pandemics
• causes an average 30,000 deaths per year
• Especially dangerous for the elderly

• B and C viruses
• infect humans only and do not cause pandemics
• virus C infections - much milder
Influenza
• Mutates frequently
• Antigenic drift: small mutations that require a new vaccine every
year
• Antigenic shift: emergence of new strains (such as H1N1 become
common when H3N2 used to be about the only human influenza
circulating)
• Co-infection with 2 viruses is possible
• Recombination of 2 segments can create a different virus
Where does influenza A virus
come from?
Human influenza A viruses start as avian (bird) influenza viruses
Migratory
water birds

Domestic birds

Humans
and other
animals
Seasonality:
drift

minor changes - antigenic

• influenza in humans is closely tied to seasonal outbreaks,
•
•
•
•

typically associated with winter months
Occurs among influenza A viruses resulting in emergence
of new variants of prevailing strains every year
New variants result in seasonal influenza each winter
Some years are worse than others – partly related to
degree of „drift
avian influenza: seems tied to bird migration patterns and
social behavior
Transmission
• Spreads easily from person to

person through coughing and
sneezing
• Transmitted by:
• inhaling respiratory aerosols containing

the virus, produced when infected
person talks, coughs, or sneezes
• 100,000 TO 1,000,000 VIRIONS PER

DROPLET
• touching an infected person or an item

contaminated with the virus and then
touching your eyes, nose, or mouth
• expelled respiratory droplets can
contaminate surfaces, and be
transmitted to mucous membranes
through direct contact
• Avian: handling of infected bird

feces
symptoms
• Sudden onset
• both systemic and respiratory symptoms can occur to varying

degrees
• systemic - fever, headache, myalgia, malaise
• respiratory - cough, sore throatdifficulty breathing

• Complications:
• recently some increase in morbidity and mortality - possible factors?
• more elderly people
• more high risk neonates
• more immunosuppressed patients
• bacterial superinfection can be severe
• Streptococcus pneumoniae the most common pathogen involved

• Staphylococcus aureus increasing, especially severe pneumonia due

to MRSA
prevention
• Vaccine:
• current CDC guidelines recommend immunizing the elderly,
pregnant women, and high risk patients (health care and lab
workers, immunosuppressed)
• Antivirals:
• E.g Tamiflu : insufficient quantities, effectiveness unclear

• Disease containment measures:
What is an influenza pandemic?
• Influenza pandemics are worldwide epidemics of

a newly emerged strain of influenza
• Few, if any, people have any immunity to the new
virus
• This allows the new virus to spread widely, easily,
and to cause more serious illness
What causes a pandemic?
• Pandemics occur when a new

avian influenza strain acquires
the ability infect people and to
spread easily person to person
• This can occur in 2 ways:
• Reassortment (an exchange of

seasonal and avian influenza genes
in a person or pig infected with both
strains)
• Mutation (an avian strain becomes
more transmissible through
adaptive mutation of the virus
during human avian influenza
infection)
Pandemic influenza:
major changes - antigenic shift
• Major changes occur in the surface antigens

of influenza A viruses by mutation or
reassortment
• Changes are more significant than those
associated with antigenic drift
• Changes lead to the emergence of potentially
pandemic strains by creating a virus that is
markedly different from recently circulating
strains so that almost all people have no preexisting immunity
Global response
Seasonal vs. pandemic influenza
• Pandemic influenza is not just a “bad flu,” it is a wholly
•
•

•

•

new threat to humans
A severe pandemic would cause social disruption unlike
anything most persons now alive have ever experienced
Compared to seasonal influenzas, pandemic influenzas
infect more people, cause more severe illness, and cause
more deaths
Seasonal influenza viruses most often cause severe
disease in the very young, the very old, and those with
chronic illnesses, but pandemic influenza strains can infect
and kill young, healthy people
The highest mortality rate in the 1918-19 pandemic was in
people aged 20-40 years
Pandemic influenza in the 20th Century

1918 “Spanish Flu” 1957 “Asian Flu” 1968 “Hong Kong Flu”
20-40 million deaths

1 million deaths

1 million deaths

H2N2

H3N2

H1N1

1920

1940

1960

1980

2000
1918 Pandemic

Highest mortality in people 20-40 years of age
- 675,000 Americans died of influenza
- 43,000 U.S. soldiers died of influenza
Lessons from past pandemics
• Occur unpredictably, not always in winter
• Great variations in mortality, severity of illness, and

pattern of illness or age most severely affected
• Rapid surge in number of cases over brief period
of time, often measured in weeks
• Tend to occur in waves of 6 - 8 weeks, subsequent
waves may be more or less severe

Key lesson – unpredictability
What about an avian influenza pandemic?
• A highly pathogenic avian influenza strain (A/H5N1)

emerged in Hong Kong in 1997, reemerged in birds and
humans in 2003, and is now circulating widely in birds in
many countries
• Since 2003, this strain has spread from birds to humans
and as of August 23, 2006 has infected 241 people (141
deaths) in 10 countries
• This strain has also been documented (rarely, so far) to
spread from person to person
• Reassortment or mutation could allow this strain to
become easily transmissible between humans – there is
no way to know if or when this will happen
Would the next pandemic be severe?
• Past pandemics provide

•

•

•
•

clues as to how humans may
be affected by a new
influenza virus and how
societies would react to a
pandemic
Info n from past pandemics
used in economic and
disease models to predict
impact of future pandemics
In US , up to 1.9 million
people could die, up to 9.9
million could be hospitalized,
and up to 90 million could
become ill
Intense pressure on
healthcare
Disruption to many aspects
of daily life
Pandemic waves
Past experience teaches us that following
emergence of a new pandemic virus:
• More than one wave of influenza is likely
• Waves typically last 6-8 weeks
• Gaps between the waves may be weeks or
months
• A subsequent wave can be worse than the first
What can be done to slow
spread of a pandemic?
• Vaccine:
• “pre-pandemic” H5N1 vaccines are in development, but would
have reduced efficacy in a pandemic due to antigenic drift
• Antivirals
• Disease containment measures:
• may be the only measures available in the early stages

of a pandemic
• may be helpful in slowing the spread of a pandemic,
allowing more time for vaccine production
Vaccine
• Because virus will be new,

there will be no vaccine
ready to protect against
pandemic influenza at the
start of a pandemic
• Specific vaccine cannot be
made until virus strain has
been identified; takes at
least 4-6 months to produce
Antiviral drugs
• Likely to be only major medical

countermeasure available early
in a pandemic
• Uncertainty about effectiveness
for treatment or prevention
• U.S. goal is to stockpile enough
antiviral drugs to treat 25% of
the U.S. population

Reproduced with permission from Roche Products Ltd. Tamiflu ®
Disease containment measures
• Isolation: restriction of
•

•
•

•

movement/separation of ill infected
persons with a contagious disease
Quarantine: restriction of
movement/separation of well
persons presumed exposed to a
contagious disease
Self-shielding: self-imposed
exclusion from infected persons or
those who may be infected
Social distancing: reducing
interactions between people to
reduce the risk of disease
transmission
Snow days: days on which offices,
schools, transportation systems are
closed or cancelled, as if there were
a major snowstorm
Other methods to reduce transmission
• Hand hygiene (cleaning hands with soap and

water or an alcohol-based hand rub)
• Respiratory hygiene, e.g., “Cover your cough”
• Cleaning and disinfection of contaminated
objects, surfaces
• Physical barriers (e.g., glass or plastic
“windows” to protect front desk workers)
• Use of personal protective equipment (PPE) in
some settings (e.g., healthcare) such as gowns,
gloves, eye, and respiratory protection
Global surveillance and planning
• Global surveillance is essential; international cooperation

critical
• International Health Regulations
• Pandemic Alert System
• http://www.who.int/influenza/preparedness/pandemic/h5n1phase/e

n/

• Planning for a possible pandemic is occurring nationally

and internationally
• National, state, local, and individual preparedness are all
important
Current WHO phase of pandemic alert for
avian influenza A(H5N1) is: ALERT
•

Alert phase: phase when influenza caused by a new
subtype has been identified in humans. Increased
vigilance and risk assessment, at local, national and
global levels, are characteristic of this phase.
• If risk assessments indicate that new virus is not developing into a

pandemic strain, a de-escalation of activities towards those in
interpandemic phase may occur.

More Related Content

What's hot

EPIDEMIOLOGY OF INFLUENZA
EPIDEMIOLOGY OF INFLUENZAEPIDEMIOLOGY OF INFLUENZA
EPIDEMIOLOGY OF INFLUENZA
MAHESWARI JAIKUMAR
 
Swine flu
Swine flu Swine flu
Swine flu
Shreejith Panicker
 
Influenza facts and prevention
Influenza facts and preventionInfluenza facts and prevention
Influenza facts and prevention
Moustapha Ramadan
 
Influenza (community medicine)
Influenza (community medicine)Influenza (community medicine)
Influenza (community medicine)
Aqsa Ijaz
 
Epidemiology H1N1 Influenza (Swine Flu)
Epidemiology  H1N1  Influenza (Swine Flu)Epidemiology  H1N1  Influenza (Swine Flu)
Epidemiology H1N1 Influenza (Swine Flu)
Prabesh Ghimire
 
Emerging & re emerging infections
Emerging & re emerging infectionsEmerging & re emerging infections
Emerging & re emerging infections
swati shikha
 
Swineflu dr rs matoria
Swineflu dr rs matoriaSwineflu dr rs matoria
Swineflu dr rs matoria
Ram Matoria
 
Influenza
InfluenzaInfluenza
Influenza
Dr.Hemant Kumar
 
Emerging and reemerging diseases.
Emerging and reemerging diseases.Emerging and reemerging diseases.
Emerging and reemerging diseases.
Aparna Ramachandran
 
Influenza in Children Recommendations for Prevention &Treatment
Influenza in Children Recommendations for Prevention &Treatment   Influenza in Children Recommendations for Prevention &Treatment
Influenza in Children Recommendations for Prevention &Treatment
Ashraf ElAdawy
 
Yellow fever
Yellow feverYellow fever
Yellow fever
tamil11
 
Influenza infection
Influenza infectionInfluenza infection
Influenza infection
mohamed osama hussein
 
Influenza
InfluenzaInfluenza
Influenza
KULDEEP VYAS
 
Infectious Disease
Infectious DiseaseInfectious Disease
Infectious Disease
DJ CrissCross
 
EPIDEMIOLOGY OF PANDEMIC INFLUENZA
EPIDEMIOLOGY OF PANDEMIC INFLUENZAEPIDEMIOLOGY OF PANDEMIC INFLUENZA
EPIDEMIOLOGY OF PANDEMIC INFLUENZA
MAHESWARI JAIKUMAR
 
Influenza
InfluenzaInfluenza
Influenza
Wal
 
Influenza
InfluenzaInfluenza
Influenza
samsungp30
 

What's hot (20)

EPIDEMIOLOGY OF INFLUENZA
EPIDEMIOLOGY OF INFLUENZAEPIDEMIOLOGY OF INFLUENZA
EPIDEMIOLOGY OF INFLUENZA
 
Swine flu
Swine flu Swine flu
Swine flu
 
Influenza facts and prevention
Influenza facts and preventionInfluenza facts and prevention
Influenza facts and prevention
 
Influenza (community medicine)
Influenza (community medicine)Influenza (community medicine)
Influenza (community medicine)
 
Epidemiology H1N1 Influenza (Swine Flu)
Epidemiology  H1N1  Influenza (Swine Flu)Epidemiology  H1N1  Influenza (Swine Flu)
Epidemiology H1N1 Influenza (Swine Flu)
 
Emerging & re emerging infections
Emerging & re emerging infectionsEmerging & re emerging infections
Emerging & re emerging infections
 
Swineflu dr rs matoria
Swineflu dr rs matoriaSwineflu dr rs matoria
Swineflu dr rs matoria
 
Swine flu ppt
Swine flu pptSwine flu ppt
Swine flu ppt
 
Swine Flu Final
Swine Flu FinalSwine Flu Final
Swine Flu Final
 
Influenza
InfluenzaInfluenza
Influenza
 
Emerging and reemerging diseases.
Emerging and reemerging diseases.Emerging and reemerging diseases.
Emerging and reemerging diseases.
 
Influenza in Children Recommendations for Prevention &Treatment
Influenza in Children Recommendations for Prevention &Treatment   Influenza in Children Recommendations for Prevention &Treatment
Influenza in Children Recommendations for Prevention &Treatment
 
Yellow fever
Yellow feverYellow fever
Yellow fever
 
Influenza infection
Influenza infectionInfluenza infection
Influenza infection
 
Influenza
InfluenzaInfluenza
Influenza
 
Infectious Disease
Infectious DiseaseInfectious Disease
Infectious Disease
 
EPIDEMIOLOGY OF PANDEMIC INFLUENZA
EPIDEMIOLOGY OF PANDEMIC INFLUENZAEPIDEMIOLOGY OF PANDEMIC INFLUENZA
EPIDEMIOLOGY OF PANDEMIC INFLUENZA
 
Influenza
InfluenzaInfluenza
Influenza
 
Swine flu
Swine fluSwine flu
Swine flu
 
Influenza
InfluenzaInfluenza
Influenza
 

Similar to Influenza

Pandemic101
Pandemic101Pandemic101
Pandemic101
Geranne Kiezebrink
 
Pandemic management at district level
Pandemic management at district levelPandemic management at district level
Pandemic management at district level
shrikrishna kesharwani
 
Pandemic influenza 2006-10-12-2
Pandemic influenza 2006-10-12-2Pandemic influenza 2006-10-12-2
Pandemic influenza 2006-10-12-2Craig Tupot
 
TOPIC 3 PRESENTATION SLIDES FINAL.pptx
TOPIC 3 PRESENTATION SLIDES FINAL.pptxTOPIC 3 PRESENTATION SLIDES FINAL.pptx
TOPIC 3 PRESENTATION SLIDES FINAL.pptx
ZimcopiersHarare
 
Influenza virus
Influenza virusInfluenza virus
Influenza virus
SaiyedShohzab
 
EPIDEMICS AND PREVENTION OF INFECTIOUS DISEASES.pptx
EPIDEMICS AND PREVENTION OF INFECTIOUS DISEASES.pptxEPIDEMICS AND PREVENTION OF INFECTIOUS DISEASES.pptx
EPIDEMICS AND PREVENTION OF INFECTIOUS DISEASES.pptx
PoonamBunwaree2
 
2020 unit 9 pandemics
2020 unit 9 pandemics2020 unit 9 pandemics
2020 unit 9 pandemics
Robert Cole
 
Infectious disease
Infectious diseaseInfectious disease
Infectious disease
Kalpana Ramachandran
 
H1N1 flu (swine flu) overview
H1N1 flu (swine flu) overviewH1N1 flu (swine flu) overview
H1N1 flu (swine flu) overview
Ahmad Thanin
 
Epidemiology and cycle of microbial diseases
Epidemiology and cycle of microbial diseasesEpidemiology and cycle of microbial diseases
Epidemiology and cycle of microbial diseasesChhaya Sawant
 
Control And Prevention Vector Borne Disease Zoonosis Disease.pdf
Control And Prevention Vector Borne Disease Zoonosis Disease.pdfControl And Prevention Vector Borne Disease Zoonosis Disease.pdf
Control And Prevention Vector Borne Disease Zoonosis Disease.pdf
Mohammed Najib Kamarolzaman
 
Influenza
InfluenzaInfluenza
Influenza
RxSlides PPT
 
L2 epi studies on com dx in hk
L2 epi studies on com dx in hkL2 epi studies on com dx in hk
L2 epi studies on com dx in hkMum Mum
 
Influenza, Bird Flu, SARS & Swine Flu.pptx
Influenza, Bird Flu, SARS & Swine Flu.pptxInfluenza, Bird Flu, SARS & Swine Flu.pptx
Influenza, Bird Flu, SARS & Swine Flu.pptx
Rahul Netragaonkar
 
2009 Sept 1 Nwrc H1 N1
2009 Sept 1 Nwrc H1 N12009 Sept 1 Nwrc H1 N1
2009 Sept 1 Nwrc H1 N1
egermann
 
Infectious Disease Epidemiology
Infectious Disease EpidemiologyInfectious Disease Epidemiology
Infectious Disease EpidemiologyArvind Kushwaha
 
The dynamics of disease transmission Dr Amita Kashyap
The dynamics of disease transmission Dr Amita KashyapThe dynamics of disease transmission Dr Amita Kashyap
The dynamics of disease transmission Dr Amita Kashyap
amitakashyap1
 
Ce ppt slides
Ce ppt slidesCe ppt slides
Ce ppt slides
See Yuan Jen
 
Bioterrorism
BioterrorismBioterrorism
Bioterrorism
thuphan95
 
10 Communicable Diseases DPT 3.pptx
10 Communicable Diseases DPT 3.pptx10 Communicable Diseases DPT 3.pptx
10 Communicable Diseases DPT 3.pptx
Noor468582
 

Similar to Influenza (20)

Pandemic101
Pandemic101Pandemic101
Pandemic101
 
Pandemic management at district level
Pandemic management at district levelPandemic management at district level
Pandemic management at district level
 
Pandemic influenza 2006-10-12-2
Pandemic influenza 2006-10-12-2Pandemic influenza 2006-10-12-2
Pandemic influenza 2006-10-12-2
 
TOPIC 3 PRESENTATION SLIDES FINAL.pptx
TOPIC 3 PRESENTATION SLIDES FINAL.pptxTOPIC 3 PRESENTATION SLIDES FINAL.pptx
TOPIC 3 PRESENTATION SLIDES FINAL.pptx
 
Influenza virus
Influenza virusInfluenza virus
Influenza virus
 
EPIDEMICS AND PREVENTION OF INFECTIOUS DISEASES.pptx
EPIDEMICS AND PREVENTION OF INFECTIOUS DISEASES.pptxEPIDEMICS AND PREVENTION OF INFECTIOUS DISEASES.pptx
EPIDEMICS AND PREVENTION OF INFECTIOUS DISEASES.pptx
 
2020 unit 9 pandemics
2020 unit 9 pandemics2020 unit 9 pandemics
2020 unit 9 pandemics
 
Infectious disease
Infectious diseaseInfectious disease
Infectious disease
 
H1N1 flu (swine flu) overview
H1N1 flu (swine flu) overviewH1N1 flu (swine flu) overview
H1N1 flu (swine flu) overview
 
Epidemiology and cycle of microbial diseases
Epidemiology and cycle of microbial diseasesEpidemiology and cycle of microbial diseases
Epidemiology and cycle of microbial diseases
 
Control And Prevention Vector Borne Disease Zoonosis Disease.pdf
Control And Prevention Vector Borne Disease Zoonosis Disease.pdfControl And Prevention Vector Borne Disease Zoonosis Disease.pdf
Control And Prevention Vector Borne Disease Zoonosis Disease.pdf
 
Influenza
InfluenzaInfluenza
Influenza
 
L2 epi studies on com dx in hk
L2 epi studies on com dx in hkL2 epi studies on com dx in hk
L2 epi studies on com dx in hk
 
Influenza, Bird Flu, SARS & Swine Flu.pptx
Influenza, Bird Flu, SARS & Swine Flu.pptxInfluenza, Bird Flu, SARS & Swine Flu.pptx
Influenza, Bird Flu, SARS & Swine Flu.pptx
 
2009 Sept 1 Nwrc H1 N1
2009 Sept 1 Nwrc H1 N12009 Sept 1 Nwrc H1 N1
2009 Sept 1 Nwrc H1 N1
 
Infectious Disease Epidemiology
Infectious Disease EpidemiologyInfectious Disease Epidemiology
Infectious Disease Epidemiology
 
The dynamics of disease transmission Dr Amita Kashyap
The dynamics of disease transmission Dr Amita KashyapThe dynamics of disease transmission Dr Amita Kashyap
The dynamics of disease transmission Dr Amita Kashyap
 
Ce ppt slides
Ce ppt slidesCe ppt slides
Ce ppt slides
 
Bioterrorism
BioterrorismBioterrorism
Bioterrorism
 
10 Communicable Diseases DPT 3.pptx
10 Communicable Diseases DPT 3.pptx10 Communicable Diseases DPT 3.pptx
10 Communicable Diseases DPT 3.pptx
 

More from thuphan95

greeks and etruscans art
greeks and etruscans artgreeks and etruscans art
greeks and etruscans artthuphan95
 
The rise of_islam
The rise of_islamThe rise of_islam
The rise of_islamthuphan95
 
American Revolution
American RevolutionAmerican Revolution
American Revolution
thuphan95
 
The Critical Period 1781-1789
The Critical Period 1781-1789The Critical Period 1781-1789
The Critical Period 1781-1789
thuphan95
 
Nationalism and economic development
Nationalism and economic developmentNationalism and economic development
Nationalism and economic developmentthuphan95
 
Sectionalism
SectionalismSectionalism
Sectionalismthuphan95
 
Political Development and Social Change
Political Development and Social Change Political Development and Social Change
Political Development and Social Change thuphan95
 
Vector borne disease and Dengue
Vector borne disease and Dengue Vector borne disease and Dengue
Vector borne disease and Dengue thuphan95
 
Vector Borne Diseases
Vector Borne DiseasesVector Borne Diseases
Vector Borne Diseases
thuphan95
 
Host pathogen interactions
Host pathogen interactionsHost pathogen interactions
Host pathogen interactions
thuphan95
 
Meningococcal disease
 Meningococcal disease Meningococcal disease
Meningococcal disease
thuphan95
 
HPV
HPVHPV
Cancer
CancerCancer
Cancer
thuphan95
 
HIV/HPV
HIV/HPVHIV/HPV
HIV/HPV
thuphan95
 
Chinese Mandarin Lesson 3.2
Chinese Mandarin Lesson 3.2Chinese Mandarin Lesson 3.2
Chinese Mandarin Lesson 3.2
thuphan95
 
Chinese Mandarin Characters Lesson 5
Chinese Mandarin Characters Lesson 5Chinese Mandarin Characters Lesson 5
Chinese Mandarin Characters Lesson 5
thuphan95
 
Mandarin Characters Lesson 6
Mandarin Characters Lesson 6Mandarin Characters Lesson 6
Mandarin Characters Lesson 6
thuphan95
 
Mandarin Character (Lesson 3)
Mandarin Character (Lesson 3)Mandarin Character (Lesson 3)
Mandarin Character (Lesson 3)
thuphan95
 

More from thuphan95 (20)

greeks and etruscans art
greeks and etruscans artgreeks and etruscans art
greeks and etruscans art
 
The rise of_islam
The rise of_islamThe rise of_islam
The rise of_islam
 
Islam
Islam  Islam
Islam
 
Judaism
Judaism Judaism
Judaism
 
American Revolution
American RevolutionAmerican Revolution
American Revolution
 
The Critical Period 1781-1789
The Critical Period 1781-1789The Critical Period 1781-1789
The Critical Period 1781-1789
 
Nationalism and economic development
Nationalism and economic developmentNationalism and economic development
Nationalism and economic development
 
Sectionalism
SectionalismSectionalism
Sectionalism
 
Political Development and Social Change
Political Development and Social Change Political Development and Social Change
Political Development and Social Change
 
Vector borne disease and Dengue
Vector borne disease and Dengue Vector borne disease and Dengue
Vector borne disease and Dengue
 
Vector Borne Diseases
Vector Borne DiseasesVector Borne Diseases
Vector Borne Diseases
 
Host pathogen interactions
Host pathogen interactionsHost pathogen interactions
Host pathogen interactions
 
Meningococcal disease
 Meningococcal disease Meningococcal disease
Meningococcal disease
 
HPV
HPVHPV
HPV
 
Cancer
CancerCancer
Cancer
 
HIV/HPV
HIV/HPVHIV/HPV
HIV/HPV
 
Chinese Mandarin Lesson 3.2
Chinese Mandarin Lesson 3.2Chinese Mandarin Lesson 3.2
Chinese Mandarin Lesson 3.2
 
Chinese Mandarin Characters Lesson 5
Chinese Mandarin Characters Lesson 5Chinese Mandarin Characters Lesson 5
Chinese Mandarin Characters Lesson 5
 
Mandarin Characters Lesson 6
Mandarin Characters Lesson 6Mandarin Characters Lesson 6
Mandarin Characters Lesson 6
 
Mandarin Character (Lesson 3)
Mandarin Character (Lesson 3)Mandarin Character (Lesson 3)
Mandarin Character (Lesson 3)
 

Recently uploaded

Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 

Recently uploaded (20)

Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 

Influenza

  • 2. Influenza • Febrile respiratory disease with systemic symptoms caused by a variety of other organisms often called „flu • Birds, swine, other mammals also affected • Highly infectious and can spread rapidly from person to person • Some strains cause more severe illness than others
  • 3. History of influenza • 412 BC - first mentioned by Hippocrates • 1580 - first pandemic described • 1580-1900 - 28 pandemics
  • 4. Types of influenza viruses • Influenza viruses divided into 3main types: influenza A, B, and C • A viruses • infect birds and other animals, as well as humans • source of seasonal influenza epidemics and all pandemics • causes an average 30,000 deaths per year • Especially dangerous for the elderly • B and C viruses • infect humans only and do not cause pandemics • virus C infections - much milder
  • 5. Influenza • Mutates frequently • Antigenic drift: small mutations that require a new vaccine every year • Antigenic shift: emergence of new strains (such as H1N1 become common when H3N2 used to be about the only human influenza circulating) • Co-infection with 2 viruses is possible • Recombination of 2 segments can create a different virus
  • 6. Where does influenza A virus come from? Human influenza A viruses start as avian (bird) influenza viruses Migratory water birds Domestic birds Humans and other animals
  • 7. Seasonality: drift minor changes - antigenic • influenza in humans is closely tied to seasonal outbreaks, • • • • typically associated with winter months Occurs among influenza A viruses resulting in emergence of new variants of prevailing strains every year New variants result in seasonal influenza each winter Some years are worse than others – partly related to degree of „drift avian influenza: seems tied to bird migration patterns and social behavior
  • 8. Transmission • Spreads easily from person to person through coughing and sneezing • Transmitted by: • inhaling respiratory aerosols containing the virus, produced when infected person talks, coughs, or sneezes • 100,000 TO 1,000,000 VIRIONS PER DROPLET • touching an infected person or an item contaminated with the virus and then touching your eyes, nose, or mouth • expelled respiratory droplets can contaminate surfaces, and be transmitted to mucous membranes through direct contact • Avian: handling of infected bird feces
  • 9. symptoms • Sudden onset • both systemic and respiratory symptoms can occur to varying degrees • systemic - fever, headache, myalgia, malaise • respiratory - cough, sore throatdifficulty breathing • Complications: • recently some increase in morbidity and mortality - possible factors? • more elderly people • more high risk neonates • more immunosuppressed patients • bacterial superinfection can be severe • Streptococcus pneumoniae the most common pathogen involved • Staphylococcus aureus increasing, especially severe pneumonia due to MRSA
  • 10. prevention • Vaccine: • current CDC guidelines recommend immunizing the elderly, pregnant women, and high risk patients (health care and lab workers, immunosuppressed) • Antivirals: • E.g Tamiflu : insufficient quantities, effectiveness unclear • Disease containment measures:
  • 11. What is an influenza pandemic? • Influenza pandemics are worldwide epidemics of a newly emerged strain of influenza • Few, if any, people have any immunity to the new virus • This allows the new virus to spread widely, easily, and to cause more serious illness
  • 12. What causes a pandemic? • Pandemics occur when a new avian influenza strain acquires the ability infect people and to spread easily person to person • This can occur in 2 ways: • Reassortment (an exchange of seasonal and avian influenza genes in a person or pig infected with both strains) • Mutation (an avian strain becomes more transmissible through adaptive mutation of the virus during human avian influenza infection)
  • 13. Pandemic influenza: major changes - antigenic shift • Major changes occur in the surface antigens of influenza A viruses by mutation or reassortment • Changes are more significant than those associated with antigenic drift • Changes lead to the emergence of potentially pandemic strains by creating a virus that is markedly different from recently circulating strains so that almost all people have no preexisting immunity
  • 15. Seasonal vs. pandemic influenza • Pandemic influenza is not just a “bad flu,” it is a wholly • • • • new threat to humans A severe pandemic would cause social disruption unlike anything most persons now alive have ever experienced Compared to seasonal influenzas, pandemic influenzas infect more people, cause more severe illness, and cause more deaths Seasonal influenza viruses most often cause severe disease in the very young, the very old, and those with chronic illnesses, but pandemic influenza strains can infect and kill young, healthy people The highest mortality rate in the 1918-19 pandemic was in people aged 20-40 years
  • 16. Pandemic influenza in the 20th Century 1918 “Spanish Flu” 1957 “Asian Flu” 1968 “Hong Kong Flu” 20-40 million deaths 1 million deaths 1 million deaths H2N2 H3N2 H1N1 1920 1940 1960 1980 2000
  • 17. 1918 Pandemic Highest mortality in people 20-40 years of age - 675,000 Americans died of influenza - 43,000 U.S. soldiers died of influenza
  • 18.
  • 19. Lessons from past pandemics • Occur unpredictably, not always in winter • Great variations in mortality, severity of illness, and pattern of illness or age most severely affected • Rapid surge in number of cases over brief period of time, often measured in weeks • Tend to occur in waves of 6 - 8 weeks, subsequent waves may be more or less severe Key lesson – unpredictability
  • 20. What about an avian influenza pandemic? • A highly pathogenic avian influenza strain (A/H5N1) emerged in Hong Kong in 1997, reemerged in birds and humans in 2003, and is now circulating widely in birds in many countries • Since 2003, this strain has spread from birds to humans and as of August 23, 2006 has infected 241 people (141 deaths) in 10 countries • This strain has also been documented (rarely, so far) to spread from person to person • Reassortment or mutation could allow this strain to become easily transmissible between humans – there is no way to know if or when this will happen
  • 21. Would the next pandemic be severe? • Past pandemics provide • • • • clues as to how humans may be affected by a new influenza virus and how societies would react to a pandemic Info n from past pandemics used in economic and disease models to predict impact of future pandemics In US , up to 1.9 million people could die, up to 9.9 million could be hospitalized, and up to 90 million could become ill Intense pressure on healthcare Disruption to many aspects of daily life
  • 22. Pandemic waves Past experience teaches us that following emergence of a new pandemic virus: • More than one wave of influenza is likely • Waves typically last 6-8 weeks • Gaps between the waves may be weeks or months • A subsequent wave can be worse than the first
  • 23. What can be done to slow spread of a pandemic? • Vaccine: • “pre-pandemic” H5N1 vaccines are in development, but would have reduced efficacy in a pandemic due to antigenic drift • Antivirals • Disease containment measures: • may be the only measures available in the early stages of a pandemic • may be helpful in slowing the spread of a pandemic, allowing more time for vaccine production
  • 24. Vaccine • Because virus will be new, there will be no vaccine ready to protect against pandemic influenza at the start of a pandemic • Specific vaccine cannot be made until virus strain has been identified; takes at least 4-6 months to produce
  • 25. Antiviral drugs • Likely to be only major medical countermeasure available early in a pandemic • Uncertainty about effectiveness for treatment or prevention • U.S. goal is to stockpile enough antiviral drugs to treat 25% of the U.S. population Reproduced with permission from Roche Products Ltd. Tamiflu ®
  • 26. Disease containment measures • Isolation: restriction of • • • • movement/separation of ill infected persons with a contagious disease Quarantine: restriction of movement/separation of well persons presumed exposed to a contagious disease Self-shielding: self-imposed exclusion from infected persons or those who may be infected Social distancing: reducing interactions between people to reduce the risk of disease transmission Snow days: days on which offices, schools, transportation systems are closed or cancelled, as if there were a major snowstorm
  • 27. Other methods to reduce transmission • Hand hygiene (cleaning hands with soap and water or an alcohol-based hand rub) • Respiratory hygiene, e.g., “Cover your cough” • Cleaning and disinfection of contaminated objects, surfaces • Physical barriers (e.g., glass or plastic “windows” to protect front desk workers) • Use of personal protective equipment (PPE) in some settings (e.g., healthcare) such as gowns, gloves, eye, and respiratory protection
  • 28. Global surveillance and planning • Global surveillance is essential; international cooperation critical • International Health Regulations • Pandemic Alert System • http://www.who.int/influenza/preparedness/pandemic/h5n1phase/e n/ • Planning for a possible pandemic is occurring nationally and internationally • National, state, local, and individual preparedness are all important
  • 29. Current WHO phase of pandemic alert for avian influenza A(H5N1) is: ALERT • Alert phase: phase when influenza caused by a new subtype has been identified in humans. Increased vigilance and risk assessment, at local, national and global levels, are characteristic of this phase. • If risk assessments indicate that new virus is not developing into a pandemic strain, a de-escalation of activities towards those in interpandemic phase may occur.